Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 2 1

Status

Completed 6Terminated 5

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Classical hematology 6

Conditions

Breast Neoplasms 1484Neoplasms 1101Carcinoma, Non-Small-Cell Lung 918Prostatic Neoplasms 802Multiple Myeloma 586Colorectal Neoplasms 535Leukemia, Myeloid, Acute 505Lung Neoplasms 489Lymphoma 455Melanoma 454Neoplasm Metastasis 451Lymphoma, Non-Hodgkin 416Leukemia 409Leukemia, Lymphocytic, Chronic, B-Cell 366Ovarian Neoplasms 357Pancreatic Neoplasms 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 334Recurrence 315Head and Neck Neoplasms 298Lymphoma, Follicular 297Myelodysplastic Syndromes 282Carcinoma, Renal Cell 272Glioblastoma 266Brain Neoplasms 265Hodgkin Disease 260Lymphoma, Large B-Cell, Diffuse 255Carcinoma, Hepatocellular 241Lymphoma, Mantle-Cell 219Squamous Cell Carcinoma of Head and Neck 214Stomach Neoplasms 210

Interventions

voxelotor 1maltodextrin 1Glutamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Has results × Anemia, Sickle Cell × Clear all
NCT03938324 2025-07-28

PiCASO

Duke University

Phase NA Completed
222 enrolled 11 charts
Classical hematology

Anemia, Sickle Cell, Cystic Fibrosis, Diabetes Mellitus, Type 1, Lupus Erythematosus, Systemic, Neoplasms, Inflammatory Bowel Diseases, Renal Insufficiency, Chronic

NCT03036813 2023-07-27

GBT_HOPE

Pfizer

Phase 3 Completed
449 enrolled 17 charts 1 FDA
Classical hematology

Anemia, Sickle Cell

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Emmaus Medical, Inc.

Phase 3 Completed
230 enrolled 19 charts 1 FDA
Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT02516579 2020-03-19

ESCORT-HU

Theravia

Completed
1,906 enrolled 9 charts 1 FDA
Classical hematology

Anemia, Sickle Cell

NCT01895361 2020-01-31

SUSTAIN

Reprixys Pharmaceutical Corporation

Phase 2 Completed
198 enrolled 18 charts 1 FDA
Classical hematology

Anemia, Sickle Cell, Priapism

NCT01572922 2019-06-11

Massive Iron Deposit Assessment

St. Jude Children's Research Hospital

Phase NA Completed
142 enrolled 15 charts
Classical hematology

Anemia, Sickle Cell, Hemochromatosis, Neoplasms, Thalassemia, Iron Overload

Data powered by HemOnc (CC BY 4.0) Colophon âš¡